These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27621622)

  • 21. HIV and antiretroviral therapy in the brain: neuronal injury and repair.
    Ellis R; Langford D; Masliah E
    Nat Rev Neurosci; 2007 Jan; 8(1):33-44. PubMed ID: 17180161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.
    Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA
    Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.
    Roy U; Ding H; Pilakka-Kanthikeel S; Raymond AD; Atluri V; Yndart A; Kaftanovskaya EM; Batrakova E; Agudelo M; Nair M
    Int J Nanomedicine; 2015; 10():5819-35. PubMed ID: 26425084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
    Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
    J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
    Wong HL; Chattopadhyay N; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1/MMP-9.
    Wu J; Zhao D; Wu S; Wang D
    Eur J Pharmacol; 2015 Feb; 748():30-6. PubMed ID: 25523481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral therapy and bone mineral measurements in HIV-infected youths.
    Zuccotti G; Viganò A; Gabiano C; Giacomet V; Mignone F; Stucchi S; Manfredini V; Marinacci F; Mora S
    Bone; 2010 Jun; 46(6):1633-8. PubMed ID: 20211284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alarmins and central nervous system inflammation in HIV-associated neurological disorders.
    Gougeon ML
    J Intern Med; 2017 May; 281(5):433-447. PubMed ID: 27862491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
    Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X
    Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetrating the Blood-Brain Barrier with New Peptide-Porphyrin Conjugates Having anti-HIV Activity.
    Mendonça DA; Bakker M; Cruz-Oliveira C; Neves V; Jiménez MA; Defaus S; Cavaco M; Veiga AS; Cadima-Couto I; Castanho MARB; Andreu D; Todorovski T
    Bioconjug Chem; 2021 Jun; 32(6):1067-1077. PubMed ID: 34033716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.
    McFarren A; Lopez L; Williams DW; Veenstra M; Bryan RA; Goldsmith A; Morgenstern A; Bruchertseifer F; Zolla-Pazner S; Gorny MK; Eugenin EA; Berman JW; Dadachova E
    AIDS; 2016 Feb; 30(4):563-72. PubMed ID: 26595540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
    Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
    Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages.
    Kang W; Marasco WA; Tong HI; Byron MM; Wu C; Shi Y; Sun S; Sun Y; Lu Y
    J Neuroinflammation; 2014 Nov; 11():195. PubMed ID: 25416164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The delicate balance between neurotoxicity and neuroprotection in the context of HIV-1 infection.
    Sénécal V; Barat C; Tremblay MJ
    Glia; 2021 Feb; 69(2):255-280. PubMed ID: 32910482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.
    Calcagno A; Romito A; Atzori C; Ghisetti V; Cardellino C; Audagnotto S; Scarvaglieri E; Lipani F; Imperiale D; Di Perri G; Bonora S
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):187-193. PubMed ID: 27826896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.
    Dallasta LM; Pisarov LA; Esplen JE; Werley JV; Moses AV; Nelson JA; Achim CL
    Am J Pathol; 1999 Dec; 155(6):1915-27. PubMed ID: 10595922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.